Prelude Capital Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Prelude Capital Management’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-275	Closed	-$323K	–	2045
2018 Q1	$323K	Buy	+275	New	+$304K	0.02%	566
2017 Q4	–	Sell	-16	Closed	-$18K	–	1835
2017 Q3	$18K	Buy	+16	New	+$18.2K	﹤0.01%	1343
2017 Q1	–	Sell	-45	Closed	-$47K	–	1863
2016 Q4	$47K	Buy	45 +40	+800%	+$18.2K	0.01%	1065
2016 Q3	$2K	Buy	+5	New	+$2.04K	﹤0.01%	1537
2015 Q2	–	Sell	-30	Closed	-$43K	–	2152
2015 Q1	$43K	Buy	+30	New	+$38.1K	0.01%	1388

Other funds holding HSTO

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

AIM

Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Prelude Capital Management's HSTO Position: Q2 2018 in Review

Prelude Capital Management sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 275 shares — an estimated $323K sold.

Prelude Capital Management first reported a position in HSTO in Q1 2015 and held it in 5 quarters. The position peaked at $323K in Q1 2018. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

Prelude Capital Management reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Prelude Capital Management sold 275 Histogen Inc. Common Stock shares in Q2 2018, an estimated $323K.
Prelude Capital Management first reported a position in Histogen Inc. Common Stock in Q1 2015 and held it in 5 quarters.
Prelude Capital Management's Histogen Inc. Common Stock position peaked at $323K in Q1 2018.
61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on Prelude Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.